eurobio-scientific产品代理
eurobio-scientific产品代理
由于 Exonhit 于 2012 年收购了 InGen，随后又于 2017 年收购了 Eurobio，新的 Eurobio Scientific 集团受益于来自每家公司商业模式的互补能力。其增长基于其分销活动的持续发展，以及其高附加值专有创新诊断和生命科学产品的开发。
Eurobio Scientific 在四个专业领域拥有广泛而多样化的专有产品组合：移植、传染病、生命科学和癌症。
在移植方面，该集团将用于运输和保存角膜移植物的介质以及促进相应手术的设备商业化。
该集团还在欧洲独家许可下将 AlloMap 商业化，这是一种用于监测心脏移植患者的分子测试。
对于传染病，该集团目前正在销售多种专有产品，包括用于评估患者对破伤风的免疫状态的 TQS®（破伤风快速棒），以及 EBX 分子生物学家族，其中包括一系列旨在识别许多病原体的测试传染病和评估感染的严重程度。
在生命科学领域，该集团开发了多种研发产品，针对政府研究机构和制药行业。 Eurobio Scientific 将细胞培养基、分子生物学试剂以及专有抗体商业化。结合自己的实验室和强大的行业专业知识，该公司还提供专门为生物技术和制药行业制造定制产品的服务。
此外，Eurobio Scientific 利用其分子生物学专业知识开发其他诊断产品。
该集团目前是其领土内领先的体外诊断独立分销商。
它向公共和私人临床实验室销售专业诊断测试，并且是法国移植 HLA 测试分销的市场领导者。
在独家经营权下，Eurobio Scientific 还将外国工业合作伙伴（美国、韩国、欧洲……）在传染病、自身免疫和质量控制领域开发的测试和自动化解决方案商业化。它还向生命科学研发实验室销售各种试剂和仪器。
凭借其工程师和产品专家，该集团为其客户提供卓越的服务，包括专门的热线电话、技术支持和服务于其客户实验室中安装的 500 多台诊断仪器的大型基地。
Eurobio Scientific 在其位于 Les Ulis（法国）、圣地亚哥（加利福尼亚）和 Rheinbach（德国）的工厂内生产其专有产品。
The Eurobio Scientific group is a French fully integrated leader
in the field of in vitro diagnostics with expertise ranging from discovery to commercialization of specialty diagnostic solutions as well as products for research in life-science.
As a result of the acquisition of InGen by Exonhit in 2012 followed by the acquisition of Eurobio in 2017, the new Eurobio Scientific group benefits from the complementary capabilities derived from each company’s business models. Its growth is based on the continued development of its distribution activities, and the development of its high added value proprietary innovative diagnostic and life-science products.
Eurobio Scientific owns a broad and diversified portfolio of proprietary products in four specialty areas : transplantation, infectious diseases, life-science and cancer.
In transplantation, the group commercializes media for the transportation and preservation of cornea grafts as well as a device to facilitate the corresponding surgery.
The group also commercializes AlloMap, a molecular test for the surveillance of heart-transplant patients, under an exclusive licence for Europe.
For infectious diseases, the group is currently marketing several proprietary products, including TQS® (Tetanus Quick Stick) for the evaluation of patients’ immune status against tetanus, and the EBX molecular biology family which includes a range of tests aiming at identifying many pathogens
responsible for infectious diseases and assessing the magnitude of the infection .
In life-science, the group develops several products for R&D, targeting both government research organizations and the pharmaceutical industry. Eurobio Scientific commercializes cell culture media, molecular biology reagents as well as proprietary antibodies. Combining its own laboratory and a strong industrial expertise, the company also offers a service dedicated to manufacturing taylor-made products for the biotechnology and pharmaceutical industries.
Additionally, Eurobio Scientific develops other diagnostic products using its molecular biology know-how.
The group is currently the leading independent distributor of in vitro diagnostics in its territory.
It markets specialty diagnostic tests to public and private clinical laboratories, and is the market leader in France for distribution of HLA tests for transplantation.
Under exclusivity, Eurobio Scientific also commercializes tests and automated solutions developed by foreign industrial partners (US, South Korea, Europe…) in the field of infectious diseases, auto-immunity and quality control. It also sells a comprehensive range of reagents and instruments to life-science R&D laboratories.
technical support and servicing a large base of more than 500 diagnostic instruments installed in its clients laboratories.
Eurobio Scientific manufactures its proprietary products in-house, in the manufacturing facilities located on its premises in Les Ulis (France), San Diego (California) and Rheinbach (Germany).
